Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5427]

Sequencing Sorafenib and Regorafenib in advanced hepatocellular carcinoma –...

Prof Josep Llovet, Dr Richard Finn

Sequencing Sorafenib and Regorafenib in advanced hepatocellular carcinoma – Brought to you by Oncology Knowledge into Practice ( Prof Josep Llovet, Dr Richard Finn )

Outcome of men with relapses after adjuvant BEP for clinical stage I nonseminoma

Dr Stefanie Fischer - The Christie NHS Foundation Trust, Manchester, UK

Outcome of men with relapses after adjuvant BEP for clinical stage I nonseminoma ( Dr Stefanie Fischer - The Christie NHS Foundation Trust, Manchester, UK )

KEYNOTE-427 cohort B: First-line pembrolizumab monotherapy for advanced non...

Prof David McDermott - Beth Israel Deaconess Medical Center, Boston, USA

KEYNOTE-427 cohort B: First-line pembrolizumab monotherapy for advanced non-clear cell renal cell carcinoma ( Prof David McDermott - Beth Israel Deaconess Medical Center, Boston, USA )

Latest from CheckMate 650: Nivolumab plus ipilimumab for the treatment of...

Dr Sumit Subudhi - MD Anderson Cancer Center, Houston, USA

Latest from CheckMate 650: Nivolumab plus ipilimumab for the treatment of metastatic castration-resistant prostate cancer ( Dr Sumit Subudhi - MD Anderson Cancer Center, Houston, USA )

Updates from the BCON trial: Longterm outcomes of hypoxia modification in...

Dr Yee Pei Song - The Christie NHS Foundation Trust, Manchester, UK

Updates from the BCON trial: Longterm outcomes of hypoxia modification in bladder preservation ( Dr Yee Pei Song - The Christie NHS Foundation Trust, Manchester, UK )

CB-839 in combination with cabozantinib in patients with clear cell and...

Prof Funda Meric-Bernstam - MD Anderson Cancer Center, Houston, USA

CB-839 in combination with cabozantinib in patients with clear cell and papillary metastatic renal cell cancer ( Prof Funda Meric-Bernstam - MD Anderson Cancer Center, Houston, USA )

KEYNOTE-365 Cohort A: Pembrolizumab plus olaparib in docetaxel-pretreated...

Prof Evan Yu - Fred Hutchinson Cancer Research Center, Seattle, USA

KEYNOTE-365 Cohort A: Pembrolizumab plus olaparib in docetaxel-pretreated patients with mCRPC ( Prof Evan Yu - Fred Hutchinson Cancer Research Center, Seattle, USA )

Adjuvant sequential chemotherapy plus radiotherapy for LABC after radical...

Prof Brian Baumann - Washington University in St. Louis, St. Louis, USA

Adjuvant sequential chemotherapy plus radiotherapy for LABC after radical cystectomy: Urothelial carcinoma subgroup analysis ( Prof Brian Baumann - Washington University in St. Louis, St. Louis, USA )

CheckMate 214: Nivolumab, ipilimumab or sunitinib in patients with advanced...

Prof Nizar Tannir - MD Anderson Cancer Center, Houston, USA

CheckMate 214: Nivolumab, ipilimumab or sunitinib in patients with advanced renal cell carcinoma ( Prof Nizar Tannir - MD Anderson Cancer Center, Houston, USA )

ASCO GU 2019: Updates on treatment and management of bladder cancer

Professor Matthew Galsky, Professor Ananya Choudhury, Professor Joaquim...

ASCO GU 2019: Updates on treatment and management of bladder cancer ( Professor Matthew Galsky, Professor Ananya Choudhury, Professor Joaquim Bellmunt, Dr Andrea Necchi )

ASCO GU 2019: Updates on non-metastatic castration-resistant prostate cancer

Prof Karim Fizazi, Dr Eleni Efstathiou, Prof Boris Hadaschik, Prof Nicholas...

ASCO GU 2019: Updates on non-metastatic castration-resistant prostate cancer ( Prof Karim Fizazi, Dr Eleni Efstathiou, Prof Boris Hadaschik, Prof Nicholas Mottet )

STREAM trial: Enzalutamide and androgen deprivation therapy with salvage...

Prof Andrew Armstrong - Duke Cancer Institute, Durham, USA

STREAM trial: Enzalutamide and androgen deprivation therapy with salvage radiation in men with high-risk PSA recurrent PC ( Prof Andrew Armstrong - Duke Cancer Institute, Durham, USA )

More from ecancer